<p>Wilms tumour (nephroblastoma) is a malignant embryonal tumour of renal tissue. It&nbsp; is&nbsp;the&nbsp; fourth&nbsp; commonest&nbsp;cancer&nbsp; amongst&nbsp; children in Ghana. About 80% of children with Wilms tumour present before 5 years of age. It can present soon after delivery. It may be associated with congenital anomalies such as hemihypertrophy and the absence of the iris (aniridia). Wilms tumour has a very good prognosis with an over 80% chance of long-term cure.</p><p><strong>CAUSES</strong></p><ul><li>Sporadic gene mutation</li></ul><p><strong>SYMPTOMS</strong></p><ul><li>Visible and or palpable abdominal mass</li><li>Fever</li><li>Blood in urine</li></ul><p><strong>SIGNS</strong></p><ul><li>Abdominal mass (palpate with care to prevent rupture or dissemination)</li><li>Haematuria (macroscopic or microscopic)</li><li>Hypertension</li><li>Associated congenital anomalies</li></ul><p><strong>INVESTIGATIONS</strong></p><ul><li>Abdominal ultrasound scan</li><li>Abdominal CT scan</li><li>Chest X-ray</li><li>Full Blood Count</li><li>Blood Urea, electrolytes and creatinine</li></ul><p><strong>TREATMENT</strong></p><p><strong>Treatment objectives</strong></p><ul><li>To obtain long term cure</li><li>To provide adequate supportive and palliative care</li></ul><p><strong>Non-pharmacological treatment</strong></p><ul><li>Nephrectomy</li><li>Radiotherapy post-surgery for advanced cases</li></ul><p><strong>Pharmacological treatment</strong></p><p><strong>A. Pre-operative treatment&nbsp;</strong>1st Line Treatment Evidence Rating: [A]</p><ul><li>Vincristine, IV,</li></ul><p><strong>And</strong></p><ul><li>Actinomycin D, IV,</li></ul><p><strong>And</strong></p><ul><li>Doxorubicin, IV, (if presence of metastases)</li></ul><p><strong>B. Post-operative treatment</strong></p><p>Evidence Rating: [A]</p><ul><li>Vincristine, IV,</li></ul><p><strong>And</strong></p><ul><li>Actinomycin D, IV,</li></ul><p><strong>And</strong></p><ul><li>Doxorubicin, IV, (depending on stage and risk category)</li></ul><p><strong>Or</strong></p><ul><li>Carboplatin, IV,</li><li>Etoposide, IV,</li><li>Doxorubicin, IV, Cyclophosphamide IV in combination (For high risk tumours)</li></ul><p><strong>C. For treatment of vomiting</strong></p><p>Evidence Rating: [A]</p><ul><li>Metoclopramide, IV or oral, 100-400 microgram/kg 8 hourly 0r</li><li>Granisetron, IV, 40 microgram/kg (max. 3 mg) stat. May repeat 12 hourly if necessary</li></ul><p><strong>Or</strong></p><ul><li>Granisetron, oral, 20 microgram/kg (max. 1 mg) within 1 hour before start of treatment</li></ul><p><strong>Then</strong></p><p>20 microgram/kg 12 hourly for up to 5 days 0r</p><ul><li>Ondansetron, IV,</li></ul><p><strong>ADULTS</strong></p><p>5 mg/m2 stat.</p><p>Repeat 8 hourly if necessary</p><p><strong>CHILDREN</strong></p><p>12-18 years; 8 mg stat. (immediatley before chemotherapy)</p><p><strong>Or</strong></p><ul><li>Ondansetron, oral,</li></ul><p><strong>ADULTS</strong></p><p>8 mg 8 hourly, administared 30 minutes before the start of chemo-</p><p>therapy Children</p><p>12-18 years;&nbsp;&nbsp;&nbsp;&nbsp; 8 mg 8-12 hourly up to 5 days</p><p>1-12 years;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 4 mg 8-12 hourly up to 5 days</p><p><strong>D. For treatment of febrile neutropenia</strong></p><ul><li>Ceftriaxone, IV, 100 mg/kg daily</li></ul><p><strong>And</strong></p><ul><li>Gentamicin, IV, 5 mg/kg daily</li></ul><p><strong>And (if still febrile after 48 hours, add)</strong></p><ul><li>Cloxacillin, IV, 25-50 mg/kg 6 hourly</li></ul><p><strong>And (if still febrile after 5 days, add)</strong></p><ul><li>Fluconazole, oral, 10 mg/kg daily</li></ul><p><strong>E. For treatment of anaemia and thrombocytopenia</strong></p><ul><li>Blood and blood product transfusions</li></ul><p>(See section on '<a href="bleeding_disorders.html">Bleeding disorders</a>')</p><p><strong>REFERRAL CRITERIA</strong></p><p>All patients should be referred to specialist centres for appropriate treatment.</p>